Strategic Acquisitions (STQN) EBIT Growth (3y) (2021 - 2026)
Powered by 
Analysis
Strategic Acquisitions (STQN) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | - |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | -18.82% |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | 57.32% |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | 53.38% |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | -41.40% |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | -13.57% |
| 10 | Strategic Acquisitions | 18.20 Mn | 17.95 Mn | - | 6.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 6.64% |
| Sep 30, 2025 | 26.98% |
| Jun 30, 2025 | 38.22% |
| Mar 31, 2025 | 20.58% |
| Dec 31, 2024 | -95.18% |
| Sep 30, 2024 | -82.69% |
| Jun 30, 2024 | -49.77% |
| Mar 31, 2024 | -48.31% |
| Dec 31, 2023 | -58.67% |
| Sep 30, 2023 | -37.48% |
| Jun 30, 2023 | -15.01% |
| Mar 31, 2023 | -39.07% |
| Sep 30, 2022 | -62.38% |
| Jun 30, 2022 | 24.31% |
| Mar 31, 2022 | -17.03% |
| Dec 31, 2021 | 42.13% |
| Sep 30, 2021 | 45.98% |
| Jun 30, 2021 | 36.93% |
| Mar 31, 2021 | 32.27% |